The Helmholtz Centre for Infection Research (HZI) and its branch Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) are partners in the project COMPACT (Collaboration on the Optimisation of Macromolecular Pharmaceutical Access to Cellular Targets), initiated by the pharma company Sanofi.
Thirteen further academic research facilities, six pharmaceutical companies and two biotechnology firms are part of the consortium. The aim of this collaboration is to improve the bioavailability of modern pharmaceutics. To achieve this, the partners have a total budget of 30 million Euro.
Further information on the website of the consortium: www.compact-research.org
The press release for the launch of COMPACT is available here.
